{"id":218390,"date":"2025-09-11T14:40:18","date_gmt":"2025-09-11T14:40:18","guid":{"rendered":"https:\/\/www.europesays.com\/us\/218390\/"},"modified":"2025-09-11T14:40:18","modified_gmt":"2025-09-11T14:40:18","slug":"guidelines-for-the-use-of-economic-evaluation-to-inform-policies-around-access-to-treatment-for-kidney-failure","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/218390\/","title":{"rendered":"Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure"},"content":{"rendered":"
  • \n

    Hariharan, S., Israni, A. K. & Danovitch, G. Long-term survival after kidney transplantation. N. Engl. J. Med. 385<\/b>, 729\u2013743 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Himmelfarb, J., Vanholder, R., Mehrotra, R. & Tonelli, M. The current and future landscape of dialysis. Nat. Rev. Nephrol. 16<\/b>, 573\u2013585 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Thurlow, J. S. et al. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am. J. Nephrol. 52<\/b>, 98\u2013107 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Harris, D. C. H. et al. Increasing access to integrated ESKD care as part of universal health coverage. Kidney Int. 95<\/b>, S1\u2013S33 (2019).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Francis, A. et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat. Rev. Nephrol. 20<\/b>, 473\u2013485 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Liyanage, T. et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385<\/b>, 1975\u20131982 (2015).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Lunney, M. et al. Availability, accessibility, and quality of conservative kidney management worldwide. Clin. J. Am. Soc. Nephrol. 16<\/b>, 79\u201387 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Kaur, G. et al. Cost of hemodialysis in a public sector tertiary hospital of India. Clin. Kidney J. 11<\/b>, 726\u2013733 (2018).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Ashuntantang, G. et al. Outcomes in adults and children with end-stage kidney disease requiring dialysis in sub-Saharan Africa: a systematic review. Lancet Glob. Health 5<\/b>, e408\u2013e417 (2017).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Olowu, W. A. et al. Outcomes of acute kidney injury in children and adults in sub-Saharan Africa: a systematic review. Lancet Glob. Health 4<\/b>, e242\u2013e250 (2016).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Jamison, D. T. et al. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd edn Vol. 9 (World Bank, 2017); https:\/\/doi.org\/10.1596\/978-1-4648-0527-1<\/a>.<\/p>\n<\/li>\n

  • \n

    Teerawattananon, Y., Dabak, S. V., Khoe, L. C., Bayani, D. B. S. & Isaranuwatchai, W. To include or not include: renal dialysis policy in the era of universal health coverage. BMJ 368<\/b>, m82 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Luyckx, V. A., Miljeteig, I., Ejigu, A. M. & Moosa, M. R. Ethical challenges in the provision of dialysis in resource-constrained environments. Semin. Nephrol. 37<\/b>, 273\u2013286 (2017).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Okpechi, I. G. et al. Building optimal and sustainable kidney care in low resource settings: the role of healthcare systems. Nephrology 26<\/b>, 948\u2013960 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Katz, I. J., Gerntholtz, T. & Naicker, S. Africa and nephrology: the forgotten continent. Nephron Clin. Pract. 117<\/b>, 320\u2013327 (2010).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Van Biesen, W. et al. Considerations on equity in management of end-stage kidney disease in low- and middle-income countries. Kidney Int. Suppl. 10<\/b>, e63\u2013e71 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., Torrance, G. W. Methods for the Economic Evaluation of Health Care Programmes. Oxford Univ. Press2015.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    World Health Organization. 2015 Global Survey on Health Technology Assessment by National Authorities: Main Findings. https:\/\/iris.who.int\/bitstream\/handle\/10665\/375063\/9789241509749-eng.pdf?sequence=1<\/a> (2015).<\/p>\n<\/li>\n

  • \n

    Kim, D. D. et al. Developing criteria for health economic quality evaluation tool. Value Health 26<\/b>, 1225\u20131234 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Caro, J. J., Briggs, A. H., Siebert, U. & Kuntz, K. M. Modeling good research practices \u2014 overview: a report of the ISPOR-SMDM modeling good research practices task force-1. Value Health 15<\/b>, 796\u2013803 (2012).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Edwards, R. T. & McIntosh, E. (eds). Applied Health Economics for Public Health Practice and Research (Oxford Univ. Press, 2019); https:\/\/doi.org\/10.1093\/med\/9780198737483.001.0001<\/a>.<\/p>\n<\/li>\n

  • \n

    Meltzer, M. I. Introduction to health economics for physicians. Lancet 358<\/b>, 993\u2013998 (2001).<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Roberts, M. et al. Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices task force-2. Value Health 15<\/b>, 804\u2013811 (2012).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Davies, M. & Cassimjee, Z. Provision of long-term renal replacement therapy to non-national patients in South Africa. South. Afr. Med. J. 111<\/b>, 615 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Thaweethamcharoen, T., Sritippayawan, S., Noparatayaporn, P. & Aiyasanon, N. Cost-utility analysis of continuous ambulatory peritoneal dialysis and automated peritoneal dialysis for Thai patients with end-stage renal disease. Value Health Reg. Issues 21<\/b>, 181\u2013187 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Bayani, D. B. S. et al. Filtering for the best policy: an economic evaluation of policy options for kidney replacement coverage in the Philippines. Nephrology 26<\/b>, 170\u2013177 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Li, B. et al. Equity\u2013efficiency trade-offs associated with alternative approaches to deceased donor kidney allocation: a patient-level simulation. Transplantation 104<\/b>, 795\u2013803 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Spinowitz, B. et al. Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review. J. Med. Econ. 22<\/b>, 593\u2013604 (2019).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Gupta, D. et al. Peritoneal dialysis \u2014 first initiative in India: a cost-effectiveness analysis. Clin. Kidney J. 15<\/b>, 128\u2013135 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Erbe, A. W., Kendzia, D., Busink, E., Carroll, S. & Aas, E. Value of an integrated home dialysis model in the United Kingdom: a cost-effectiveness analysis. Value Health 26<\/b>, 984\u2013994 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Chalkidou, K., Culyer, A. J. & Nemzoff, C. Perspective in Economic Evaluations of Health Care Interventions in Low- and Middle-Income Countries \u2014 One Size Does Not Fit All. https:\/\/www.cgdev.org\/sites\/default\/files\/perspective-economic-evaluations-healthcare-interventions-low-and-middle-income.pdf<\/a> (Center for Global Development, 2018).<\/p>\n<\/li>\n

  • \n

    Sittimart, M. et al. An overview of the perspectives used in health economic evaluations. Cost. Eff. Resour. Alloc.22<\/b>, 41 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Drummond, M. et al. Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value Health 12<\/b>, 409\u2013418 (2009).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Sassi, F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan. 21<\/b>, 402\u2013408 (2006).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Donnelly, J. Comparative effectiveness research (updated). Health Aff. (Millwood) https:\/\/doi.org\/10.1377\/hpb20101008.552571<\/a> (2010).<\/p>\n<\/li>\n

  • \n

    Rand, L. Z. & Kesselheim, A. S. Controversy over using quality-adjusted life-years in cost-effectiveness analyses: a systematic literature review. Health Aff. 40<\/b>, 1402\u20131410 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Beresniak, A. et al. Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project. Pharmacoeconomics 33<\/b>, 61\u201369 (2015).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Anand, S. & Hanson, K. Disability-adjusted life years: a critical review. J. Health Econ. 16<\/b>, 685\u2013702 (1997).<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Tomeny, E. M. et al. Rethinking tuberculosis morbidity quantification: a systematic review and critical appraisal of TB disability weights in cost-effectiveness analyses. Pharmacoeconomics 42<\/b>, 1209\u20131236 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Arnesen, T. & Nord, E. The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ 319<\/b>, 1423\u20131425 (1999).<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Sanders, G. D. et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA 316<\/b>, 1093\u20131103 (2016).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Sharma, D., Aggarwal, A. K., Downey, L. E. & Prinja, S. National healthcare economic evaluation guidelines: a cross-country comparison. Pharmacoecon. Open. 5<\/b>, 349\u2013364 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Daccache, C., Karam, R., Rizk, R., Evers, S. M. A. A. & Hiligsmann, M. The development process of economic evaluation guidelines in low- and middle-income countries: a systematic review. Int. J. Technol. Assess. Health Care 38<\/b>, e35 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Verguet, S., Kim, J. J. & Jamison, D. T. Extended cost-effectiveness analysis for health policy assessment: a tutorial. Pharmacoeconomics 34<\/b>, 913\u2013923 (2016).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Norheim, O. F. et al. Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis. Cost. Eff. Resour. Alloc. 12<\/b>, 18 (2014).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Elsayed, M. E., Morris, A. D., Li, X., Browne, L. D. & Stack, A. G. Propensity score matched mortality comparisons of peritoneal and in-centre haemodialysis: systematic review and meta-analysis. Nephrol. Dial. Transplant. 35<\/b>, 2172\u20132182 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Luo, P.-T. et al. Impact of peritoneal dialysis modality on patient and PD survival: a systematic review. Perit. Dial. Int. 43<\/b>, 128\u2013138 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Chander, S. et al. Mortality and mode of dialysis: meta-analysis and systematic review. BMC Nephrol. 25<\/b>, 1 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Cheng, L., Hu, N., Song, D. & Chen, Y. Mortality of peritoneal dialysis versus hemodialysis in older adults: an updated systematic review and meta-analysis. Gerontology 70<\/b>, 461\u2013478 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Zazzeroni, L., Pasquinelli, G., Nanni, E., Cremonini, V. & Rubbi, I. Comparison of quality of life in patients undergoing hemodialysis and peritoneal dialysis: a systematic review and meta-analysis. Kidney Blood Press. Res. 42<\/b>, 717\u2013727 (2017).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Chauhan, A. S. et al. Validating the rigour of adaptive methods of economic evaluation. BMJ Glob. Health 8<\/b>, e012277 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Karopadi, A. N., Mason, G., Rettore, E. & Ronco, C. Cost of peritoneal dialysis and haemodialysis across the world. Nephrol. Dial. Transplant. 28<\/b>, 2553\u20132569 (2013).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Ready, A. R., Nath, J., Milford, D. V., Adu, D. & Jewitt-Harris, J. Establishing sustainable kidney transplantation programs in developing world countries: a 10-year experience. Kidney Int. 90<\/b>, 916\u2013920 (2016).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Nemzoff, C. et al. Rapid cost-effectiveness analysis: hemodialysis versus peritoneal dialysis for patients with acute kidney injury in Rwanda. Cost. Eff. Resour. Alloc. 22<\/b>, 35 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Wilkinson, T. et al. The international decision support initiative reference case for economic evaluation: an aid to thought. Value Health 19<\/b>, 921\u2013928 (2016).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Attema, A. E., Brouwer, W. B. F. & Claxton, K. Discounting in economic evaluations. Pharmacoeconomics 36<\/b>, 745\u2013758 (2018).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Haacker, M., Hallett, T. B. & Atun, R. On discount rates for economic evaluations in global health. Health Policy Plan. 35<\/b>, 107\u2013114 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Haacker, M., Hallett, T. B. & Atun, R. On time horizons in health economic evaluations. Health Policy Plan. 35<\/b>, 1237\u20131243 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Adeagbo, C. U., Rattanavipapong, W., Guinness, L. & Teerawattananon, Y. The development of the guide to economic analysis and research (GEAR) online resource for low- and middle-income countries\u2019 health economics practitioners: a commentary. Value Health 21<\/b>, 569\u2013572 (2018).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Bertram, M. Y., Lauer, J. A., Stenberg, K. & Edejer, T. T. T. Methods for the economic evaluation of health care interventions for priority setting in the health system: an update from WHO CHOICE. Int. J. Health Policy Manag. 10, 673\u2013677 (2021).<\/p>\n

    PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Canadian Agency for Drugs and Technologies in Health. Guidelines for the Economic Evaluation of Health Technologies: Canada 4th edn. https:\/\/www.cda-amc.ca\/sites\/default\/files\/pdf\/guidelines_for_the_economic_evaluation_of_health_technologies_canada_4th_ed.pdf<\/a> (2017).<\/p>\n<\/li>\n

  • \n

    Harper, A., Mustafee, N. & Yearworth, M. Facets of trust in simulation studies. Eur. J. Oper. Res. 289<\/b>, 197\u2013213 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Stahl, J. E. Modelling methods for pharmacoeconomics and health technology assessment. Pharmacoeconomics 26<\/b>, 131\u2013148 (2008).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Siebert, U. et al. State-transition modeling. Med. Decis. Mak. 32<\/b>, 690\u2013700 (2012).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Soares, M. et al. Recommendations on the use of structured expert elicitation protocols for healthcare decision making: a good practices report of an ISPOR task force. Value Health 27<\/b>, 1469\u20131478 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Goeree, R. et al. Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Curr. Med. Res. Opin. 23<\/b>, 671\u2013682 (2007).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Teerawattananon, Y. & Tritasavit, N. A learning experience from price negotiations for vaccines. Vaccine 33<\/b>, A11\u2013A12 (2015).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Turner, H. C., Lauer, J. A., Tran, B. X., Teerawattananon, Y. & Jit, M. Adjusting for inflation and currency changes within health economic studies. Value Health 22<\/b>, 1026\u20131032 (2019).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Vassall, A. et al. Reference Case for Estimating the Costs of Global Health Services and Interventions. https:\/\/ghcosting.org\/pages\/standards\/reference_case<\/a> (2017).<\/p>\n<\/li>\n

  • \n

    NICE Decision Support Unit. Survival Analysis TSD. https:\/\/www.sheffield.ac.uk\/nice-dsu\/tsds\/survival-analysis<\/a> (2022).<\/p>\n<\/li>\n

  • \n

    Coyle, D., Haines, A. & Lee, K. Extrapolating Clinical Evidence within Economic Evaluations: CADTH Methods and Guidelines (Canadian Agency for Drugs and Technologies in Health, 2023); https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK594389\/<\/a>.<\/p>\n<\/li>\n

  • \n

    Afiatin et al. Economic evaluation of policy options for dialysis in end-stage renal disease patients under the universal health coverage in Indonesia. PLoS ONE12<\/b>, e0177436 (2017).<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Wyld, M., Morton, R. L., Hayen, A., Howard, K. & Webster, A. C. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med. 9<\/b>, e1001307 (2012).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Liem, Y. S., Bosch, J. L. & Hunink, M. G. M. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health 11<\/b>, 733\u2013741 (2008).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Chuasuwan, A., Pooripussarakul, S., Thakkinstian, A., Ingsathit, A. & Pattanaprateep, O. Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. Health Qual. Life Outcomes 18<\/b>, 191 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Jensen, C. E., S\u00f8rensen, P. & Petersen, K. D. In Denmark kidney transplantation is more cost-effective than dialysis. Dan. Med. J. 61<\/b>, A4796 (2014).<\/p>\n

    PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2021 (GBD 2021) Disability Weights (Institute for Health Metrics and Evaluation, 2024); https:\/\/doi.org\/10.6069\/485b-dx41<\/a>.<\/p>\n<\/li>\n

  • \n

    Bilcke, J. & Beutels, P. Generating, presenting, and interpreting cost-effectiveness results in the context of uncertainty: a tutorial for deeper knowledge and better practice. Med. Decis. Mak. 42<\/b>, 421\u2013435 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Sullivan, S. D. et al. Budget impact analysis \u2014 principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II task force. Value Health 17<\/b>, 5\u201314 (2014).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Mauskopf, J. A. et al. Principles of good practice for budget impact analysis: report of the ISPOR task force on good research practices \u2014 budget impact analysis. Value Health 10<\/b>, 336\u2013347 (2007).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Briggs, A. H. et al. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force-6. Value Health 15<\/b>, 835\u2013842 (2012).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Chen, H.-F. et al. The magnitude of the health and economic impact of increased organ donation on patients with end-stage renal disease. MDM Policy Pract. 6<\/b>, 23814683211063418 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Axelrod, D. A. et al. An economic assessment of contemporary kidney transplant practice. Am. J. Transplant. 18<\/b>, 1168\u20131176 (2018).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    NICE. in NICE Health Technology Evaluations: The Manual (National Institute for Health and Care Excellence, 2023).<\/p>\n<\/li>\n

  • \n

    Thokala, P., Ochalek, J., Leech, A. A. & Tong, T. Cost-effectiveness thresholds: the past, the present and the future. Pharmacoeconomics 36<\/b>, 509\u2013522 (2018).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Isaranuwatchai, W. et al. An empirical study looking at the potential impact of increasing cost-effectiveness threshold on reimbursement decisions in Thailand. Health Policy Technol. 13<\/b>, 100927 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Bertram, M. Y. et al. Cost\u2013effectiveness thresholds: pros and cons. Bull. World Health Organ. 94<\/b>, 925 (2016).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Mangoya, D., Barham, L., Moyo, E., Moyo, P. & Dzinamarira, T. The use of economic evaluation tools in essential health benefits package selection for universal health coverage. Value Health Reg. Issues 36<\/b>, 1\u20139 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Eregata, G. T. et al. Generalised cost-effectiveness analysis of 159 health interventions for the Ethiopian essential health service package. Cost. Eff. Resour. Alloc. 19<\/b>, 2 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Eckman, M. H., Woodle, E. S., Thakar, C. V., Alloway, R. R. & Sherman, K. E. Cost-effectiveness of using kidneys from HCV-viremic donors for transplantation into HCV-uninfected recipients. Am. J. Kidney Dis. 75<\/b>, 857\u2013867 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Pichon-Riviere, A., Drummond, M., Palacios, A., Garcia-Marti, S. & Augustovski, F. Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures. Lancet Glob. Health 11<\/b>, e833\u2013e842 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Sampson, C. et al. Supply-side cost-effectiveness thresholds: questions for evidence-based policy. Appl. Health Econ. Health Policy 20<\/b>, 651\u2013667 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Strong, M., Oakley, J. E. & Chilcott, J. Managing structural uncertainty in health economic decision models: a discrepancy approach. J. R. Stat. Soc. Ser. C. Appl. Stat. 61<\/b>, 25\u201345 (2012).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Haji Ali Afzali, H., Bojke, L. & Karnon, J. Model structuring for economic evaluations of new health technologies. Pharmacoeconomics 36<\/b>, 1309\u20131319 (2018).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Jackson, C. H. et al. Value of information analysis in models to inform health policy. Annu. Rev. Stat. Appl. 9<\/b>, 95 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Senanayake, S., Healy, H., McPhail, S. M., Baboolal, K. & Kularatna, S. Cost-effectiveness and budget impact analysis of implementing a \u2018Soft Opt-Out\u2019 system for kidney donation in Australia. Appl. Health Econ. Health Policy 20<\/b>, 769\u2013779 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Botwright, S., Win, E. M., Kapol, N., Benjawan, S. & Teerawattananon, Y. Cost-utility analysis of universal maternal pertussis immunisation in Thailand: a comparison of two model structures. Pharmacoeconomics 41<\/b>, 77\u201391 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Rothery, C. et al. Value of information analytical methods: report 2 of the ISPOR value of information analysis emerging good practices task force. Value Health 23<\/b>, 277\u2013286 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Fenwick, E. et al. Value of information analysis for research decisions \u2014 an introduction: report 1 of the ISPOR value of information analysis emerging good practices task force. Value Health 23<\/b>, 139\u2013150 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Fenwick, E., Marshall, D. A., Levy, A. R. & Nichol, G. Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation. BMC Health Serv. Res. 6<\/b>, 52 (2006).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Jackson, C., et al. A guide to value of information methods for prioritising research in health impact modelling. Epidemiol. Methods 10<\/b>, 20210012.<\/p>\n<\/li>\n

  • \n

    Health Intervention and Technology Assessment Program. Guidelines comparison. Guide to Economic Analysis and Research (GEAR) Online Resource. https:\/\/www.gear4health.com\/gear\/health-economic-evaluation-guidelines<\/a> (2024).<\/p>\n<\/li>\n

  • \n

    Philips, Z., Bojke, L., Sculpher, M., Claxton, K. & Golder, S. Good practice guidelines for decision-analytic modelling in health technology assessment. Pharmacoeconomics 24<\/b>, 355\u2013371 (2006).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Husereau, D. et al. Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. Pharmacoeconomics 40<\/b>, 601\u2013609 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Eddy, D. M. et al. Model transparency and validation. Med. Decis. Mak. 32<\/b>, 733\u2013743 (2012).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    World Health Organization. Value-based Pricing: WHO Guideline on Country Pharmaceutical Pricing Policies. A Plain Language Summary. https:\/\/iris.who.int\/bitstream\/handle\/10665\/341896\/9789240024595-eng.pdf<\/a> (2021).<\/p>\n<\/li>\n

  • \n

    Dom\u00ednguez, J., Harrison, R. & Atal, R. Cost\u2013benefit estimation of cadaveric kidney transplantation: the case of a developing country. Transpl. Proc. 43<\/b>, 2300\u20132304 (2011).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Hryshchuk, S. M. & Parii, V. D. Cost-effectiveness of dialysis and kidney transplantation to treat end-stage renal disease in Ukraine. Wiad. Lekarskie 77<\/b>, 765\u2013771 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Rosselli, D., Rueda, J.-D. & Diaz, C. Cost-effectiveness of kidney transplantation compared with chronic dialysis in end-stage renal disease. Saudi J. Kidney Dis. Transplant. 26<\/b>, 733 (2015).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Moradpour, A., Hadian, M. & Tavakkoli, M. Economic evaluation of end stage renal disease treatments in Iran. Clin. Epidemiol. Glob. Health 8<\/b>, 199\u2013204 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Hong, Z. et al. Economic evaluation of three dialysis methods in patients with end-stage renal disease in China. Int. Urol. Nephrol. 55<\/b>, 1247\u20131254 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Pike, E., Hamidi, V., Ringerike, T., Wisloff, T. & Klemp, M. More use of peritoneal dialysis gives significant savings: a systematic review and health economic decision model. J. Clin. Med. Res. 9<\/b>, 104\u2013116 (2017).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Putri, S. et al. Supporting dialysis policy for end stage renal disease (ESRD) in Indonesia: an updated cost-effectiveness model. BMC Res. Notes 15<\/b>, 359 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Sinclair, A. et al. Dialysis Modalities for the Treatment of End-Stage Kidney Disease: A Health Technology Assessment. CADTH Optimal Use Report No. 6.2b (Canadian Agency for Drugs and Technologies in Health, 2017); https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK531991\/<\/a>.<\/p>\n<\/li>\n

  • \n

    Yang, F., Lau, T. & Luo, N. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore. Nephrology 21<\/b>, 669\u2013677 (2016).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Liu, J. et al. Financial implications of dialysis modalities in the developing world: a Chinese perspective. Perit. Dial. Int. 40<\/b>, 193\u2013201 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Haller, M., Gutjahr, G., Kramar, R., Harnoncourt, F. & Oberbauer, R. Cost-effectiveness analysis of renal replacement therapy in Austria. Nephrol. Dial. Transplant. 26<\/b>, 2988\u20132995 (2011).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Shimizu, U. et al. Cost-effectiveness achieved through changing the composition of renal replacement therapy in Japan. J. Med. Econ. 15<\/b>, 444\u2013453 (2012).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Surendra, N. K. et al. Cost utility analysis of end stage renal disease treatment in Ministry of Health dialysis centres, Malaysia: hemodialysis versus continuous ambulatory peritoneal dialysis. PLoS ONE14<\/b>, e0218422 (2019).<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Villa, G. et al. Cost-effectiveness analysis of the Spanish renal replacement therapy program. Perit. Dial. Int. 32<\/b>, 192\u2013199 (2012).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Treharne, C., Liu, F. X., Arici, M., Crowe, L. & Farooqui, U. Peritoneal dialysis and in-centre haemodialysis: a cost-utility analysis from a UK payer perspective. Appl. Health Econ. Health Policy 12<\/b>, 409\u2013420 (2014).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Yang, F., Liao, M., Wang, P. & Liu, Y. Cost-effectiveness analysis of renal replacement therapy strategies in Guangzhou city, southern China. BMJ Open. 11<\/b>, e039653 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Yousefi, M., Rezaei, S., Hajebrahimi, S., Falsafi, N. & Keshvari-Shad, F. Peritoneal dialysis vs. hemodialysis among patients with end-stage renal disease in Iran: which is more cost-effective? BMC Nephrol. 25<\/b>, 85 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Beby, A. T., Cornelis, T., Zinck, R. & Liu, F. X. Cost-effectiveness of high dose hemodialysis in comparison to conventional in-center hemodialysis in the Netherlands. Adv. Ther. 33<\/b>, 2032\u20132048 (2016).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Liu, F. X., Treharne, C., Arici, M., Crowe, L. & Culleton, B. High-dose hemodialysis versus conventional in-center hemodialysis: a cost-utility analysis from a UK payer perspective. Value Health 18<\/b>, 17\u201324 (2015).<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Ramponi, F. et al. Cost-effectiveness analysis of online hemodiafiltration versus high-flux hemodialysis. Clinicoecon. Outcomes Res. 8<\/b>, 531\u2013540 (2016).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Augusty\u0144ska, J. et al. Automated peritoneal dialysis with remote patient monitoring: clinical effects and economic consequences for Poland. Value Health Reg. Issues 40<\/b>, 53\u201362 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Moosa, M. R., Maree, J. D., Chirehwa, M. T. & Benatar, S. R. Use of the \u2018Accountability for Reasonableness\u2019 approach to improve fairness in accessing dialysis in a middle-income country. PLoS ONE11<\/b>, e0164201 (2016).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Kiberd, B. A., Tennankore, K. K. & Vinson, A. J. Comparing the net benefits of adult deceased donor kidney transplantation for a patient on the preemptive waiting list vs a patient receiving dialysis. JAMA Netw. Open 5<\/b>, e2223325 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Senanayake, S. et al. Deceased donor kidney allocation: an economic evaluation of contemporary longevity matching practices. BMC Health Serv. Res. 20<\/b>, 931 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Smith, J. M. et al. Cost implications of new national allocation policy for deceased donor kidneys in the United States. Transplantation 100<\/b>, 879\u2013885 (2016).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Wong, C. K. H. et al. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy. BMC Nephrol. 21<\/b>, 42 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Axelrod, D. A. et al. The clinical and economic benefit of CMV matching in kidney transplant: a decision analysis. Transplantation 106<\/b>, 1227\u20131232 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Bamforth, R. J. et al. Expanding access to high KDPI kidney transplant for recipients aged 60\u2009y and older: cost utility and survival. Transpl. Direct 10<\/b>, e1629 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Ellison, T. A. et al. Evaluating cost-effectiveness in using high-kidney donor profile index organs. Transpl. Proc. 55<\/b>, 2333\u20132344 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Hedley, J. A. et al. Cost-effectiveness of interventions to increase utilization of kidneys from deceased donors with primary brain malignancy in an Australian setting. Transpl. Direct 9<\/b>, e1474 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Kadatz, M., Klarenbach, S., Gill, J. & Gill, J. S. Cost-effectiveness of using kidneys from hepatitis C nucleic acid test-positive donors for transplantation in hepatitis C-negative recipients. Am. J. Transplant. 18<\/b>, 2457\u20132464 (2018).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Senanayake, S. et al. Donor kidney quality and transplant outcome: an economic evaluation of contemporary practice. Value Health 23<\/b>, 1561\u20131569 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Shah, K. K. et al. Cost-effectiveness of kidney transplantation from donors at increased risk of blood-borne virus infection transmission. Transplantation 107<\/b>, 2028\u20132042 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Koto, P. et al. An ex-ante cost-utility analysis of the deemed consent legislation compared to expressed consent for kidney transplantations in Nova Scotia. Cost. Eff. Resour. Alloc. 20<\/b>, 55 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Cavallo, M. C. et al. Cost-effectiveness of kidney transplantation from DCD in Italy. Transpl. Proc. 46<\/b>, 3289\u20133296 (2014).<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Barnieh, L., Gill, J. S., Klarenbach, S. & Manns, B. J. The cost-effectiveness of using payment to increase living donor kidneys for transplantation. Clin. J. Am. Soc. Nephrol. 8<\/b>, 2165\u20132173 (2013).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Karnon, J. et al. Modeling using discrete event simulation. Med. Decis. Mak. 32<\/b>, 701\u2013711 (2012).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Health Intervention and Technology Assessment Program. Plant-A-Tree \u2014 an open access decision tree builder. Guide to Economic Analysis and Research (GEAR) Online Resource. https:\/\/www.gear4health.com\/page\/i\/plant-a-tree<\/a> (2024).<\/p>\n<\/li>\n

  • \n

    Manns, B. J., Taub, K. J. & Donaldson, C. Economic evaluation and end-stage renal disease: from basics to bedside. Am. J. Kidney Dis. 36<\/b>, 12\u201328 (2000).<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Glossary: Health Economic Terms. https:\/\/yhec.co.uk\/resources\/glossary\/<\/a> (York Health Economics Consortium, 2016).<\/p>\n<\/li>\n

  • \n

    Glossary of Terms for Health Economics and Systematic Review. https:\/\/methods.cochrane.org\/economics\/sites\/methods.cochrane.org.economics\/files\/public\/uploads\/ccemg_website_glossary.pdf<\/a>.<\/p>\n<\/li>\n

  • \n

    International Society of Nephrology. The ISN Framework for Developing Dialysis Programs in Low-Resource Settings. https:\/\/www.theisn.org\/wp-content\/uploads\/2021\/03\/ISN-Framework-Dialysis-Report-HIRES.pdf<\/a> (2021).<\/p>\n<\/li>\n

  • \n

    Bertram, M., Dhaene, G. & Tan-Torres Edejer, T. (eds). Institutionalizing Health Technology Assessment Mechanisms: A How to Guide. https:\/\/www.who.int\/publications\/i\/item\/9789240020665<\/a> (World Health Organization, 2021).<\/p>\n<\/li>\n","protected":false},"excerpt":{"rendered":"Hariharan, S., Israni, A. K. & Danovitch, G. Long-term survival after kidney transplantation. N. Engl. J. Med. 385,…\n","protected":false},"author":3,"featured_media":218391,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[834,210,1141,79744,1142,3209,65978,119219,67,132,68],"class_list":{"0":"post-218390","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health-care","8":"tag-general","9":"tag-health","10":"tag-health-care","11":"tag-health-care-economics","12":"tag-healthcare","13":"tag-medicine-public-health","14":"tag-nephrology","15":"tag-renal-replacement-therapy","16":"tag-united-states","17":"tag-unitedstates","18":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115186190610544400","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/218390","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=218390"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/218390\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/218391"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=218390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=218390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=218390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}